Skip to main content

Advertisement

Log in

The Usefulness of CD34, PCNA Immunoreactivity, and Histopathological Findings for Prediction of Pain Persistence After the Removal of Endometrioma

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Endometriosis is an estrogen-dependent inflammatory disease that causes infertility and chronic pelvic pain. Ovarian endometrioma is the most common form of endometriosis, and conservative surgery is the main preferred therapeutic approach for endometrioma-associated symptoms. The aim of this study was to investigate the persistence of cyclic and noncyclic pelvic pain (NCPP) after endometrioma excision and their relationship to clinical and histopathological findings. In this prospective observational study, 41 symptomatic patients were evaluated for the presence of pain symptoms 3 to 6 months after endometrioma excision. Tissue specimens of endometrioma were collected during the operation and embedded in paraffin. The persistence of pain was 41.4%. Surgical excision of endometrioma significantly decreased NCPP and dysmenorrhea, but not dyspareunia (P <.0001, P =.0001, and P =.25, respectively). Histopathological changes, including depth of endometriosis penetration into the cyst wall, the presence of macrophage infiltration, and vascularity of endometrioma cyst walls were significantly higher in patients with pain persistence than in patients without pain persistence (P =.0034, P =.0042, and P =.0007, respectively). Moreover, proliferating cell nuclear antigen (PCNA) and CD34 immunoreactivity in both glandular and stromal cells and vascular endothelium were significantly higher in patients with pain persistence (P =.0079 and P =.0025, respectively). Additionally, these histopathological changes and PCNA and CD34 immunoreactivity were significantly correlated with the persistence of NCPP and dysmenorrhea. The discovered differences in patients with endometrioma with or without pain persistence may indicate a possible relationship between endometrioma-associated pain and histopathological variability of endometrioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Missmer SA, Hankinson SE, Spiegelman D, et al. Reproductive history and endometriosis among premenopausal women. Obstet Gynecol. 2004;104(5 pt 1):965–974.

    PubMed  Google Scholar 

  2. Yamamoto A, Johnstone EB, Bloom MS, Huddleston HG, Fujimoto VY. A higher prevalence of endometriosis among Asian women does not contribute to poorer IVF outcomes. J Assist Reprod Genet. 2017;34(6):765–774.

    PubMed  PubMed Central  Google Scholar 

  3. Soliman AM, Coyne KS, Zaiser E, Castelli-Haley J, Fuldeore MJ. The burden of endometriosis symptoms on health-related quality of life in women in the United States: a cross-sectional study. J Psychosom Obstet Gynaecol. 2017;38(4):238–248.

    PubMed  Google Scholar 

  4. Barcena de Arellano ML, Mechsner S. The peritoneum—an important factor for pathogenesis and pain generation in endometriosis. J Mol Med (Berl). 2014;92(6):595–602.

    CAS  Google Scholar 

  5. Sinaii N, Cleary SD, Younes N, Ballweg ML, Stratton P. Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience. Fertil Steril. 2007;87(6):1277–1286.

    PubMed  Google Scholar 

  6. Shakiba K, Bena JF, McGill KM, Minger J, Falcone T. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008;111(6):1285–1292.

    PubMed  Google Scholar 

  7. Morotti M, Vincent K, Brawn J, Zondervan KT, Becker CM. Peripheral changes in endometriosis-associated pain. Hum Reprod Update. 2014;20(5):717–736.

    PubMed  Google Scholar 

  8. Redwine DB. Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease. Fertil Steril. 1999;72(2):310–315.

    CAS  PubMed  Google Scholar 

  9. Busacca M, Vignali M. Ovarian endometriosis from pathogenesis to surgical treatment. Curr opin Obstet Gynecol. 2003;15(4):321–326.

    PubMed  Google Scholar 

  10. Donnez J, Pirard C, Smets M, Jadoul P, Squifflet J. Surgical management of endometriosis. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):329–348.

    PubMed  Google Scholar 

  11. Guo SW, Olive DL. Two unsuccessful clinical trials on endometriosis and a few lessons learned. Gynecol Obstet Invest. 2007;64(1):24–35.

    CAS  PubMed  Google Scholar 

  12. Vercellini P, Crosignani PG, Abbiati A, Somigliana E, Vigano P, Fedele L. The effect of surgery for symptomatic endometriosis: the other side of the story. Hum Reprod Update. 2009;15(2):177–188.

    CAS  PubMed  Google Scholar 

  13. Urman B, Alper E, Yakin K, et al. Removal of unilateral endometriomas is associated with immediate and sustained reduction in ovarian reserve. Reprod Biomed Online. 2013;27(2):212–216.

    CAS  PubMed  Google Scholar 

  14. Api M, Boza AT, Kayatas S, Eroglu M. Effect of surgical removal of endometriomas on cyclic and noncyclic pelvic pain. Int J Fertil Steril. 2015;9(2):183–188.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Alborzi S, Momtahan M, Parsanezhad ME, Dehbashi S, Zolghadri J, Alborzi S. A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas. Fertil Steril. 2004;82(6):1633–1637.

    PubMed  Google Scholar 

  16. Busacca M, Marana R, Caruana P, et al. Recurrence of ovarian endometrioma after laparoscopic excision. Am J Obstet Gynecol. 1999;180(3 pt 1):519–523.

    CAS  PubMed  Google Scholar 

  17. Liu X, Yuan L, Shen F, Zhu Z, Jiang H, Guo SW. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol. 2007;109(6):1411–1420.

    PubMed  Google Scholar 

  18. Vignali M, Bianchi S, Candiani M, Spadaccini G, Oggioni G, Busacca M. Surgical treatment of deep endometriosis and risk of recurrence. J Minim Invasive Gynecol. 2005;12(6):508–513.

    PubMed  Google Scholar 

  19. Anaf V, Simon P, El Nakadi I, et al. Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod. 2000;15(8):1744–1750.

    CAS  PubMed  Google Scholar 

  20. Wu J, Xie H, Yao S, Liang Y. Macrophage and nerve interaction in endometriosis. J Neuroinflammation. 2017;14(1):53.

    PubMed  PubMed Central  Google Scholar 

  21. Odagiri K, Konno R, Fujiwara H, Netsu S, Yang C, Suzuki M. Smooth muscle metaplasia and innervation in interstitium of endometriotic lesions related to pain. Fertil Steril. 2009;92(5):1525–1531.

    PubMed  Google Scholar 

  22. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis:1996. Fertil Steril. 1997;67(5):817–821.

    Google Scholar 

  23. Lund I, Lundeberg T, Sandberg L, Budh CN, Kowalski J, Svensson E. Lack of interchangeability between visual analogue and verbal rating pain scales: a cross sectional description of pain etiology groups. BMC Med Res Methodol. 2005;5:31.

    PubMed  PubMed Central  Google Scholar 

  24. Inan S, Kuscu NK, Vatansever S, Ozbilgin K, Koyuncu F, Sayhan S. Increased vascular surface density in ovarian endometriosis. Gynecol Endocrinol. 2003;17(2):143–150.

    CAS  PubMed  Google Scholar 

  25. Ceyhan ST, Onguru O, Baser I, Gunhan O. Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis. Fertil Steril. 2008;90(4):988–993.

    CAS  PubMed  Google Scholar 

  26. Di Carlo C, Bonifacio M, Tommaselli GA, Bifulco G, Guerra G, Nappi C. Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium. Fertil Steril. 2009;91(6):2315–2323.

    PubMed  Google Scholar 

  27. Li Y, Adur MK, Kannan A, et al. Progesterone alleviates endometriosis via inhibition of uterine cell proliferation, inflammation and angiogenesis in an immunocompetent mouse model. PLoS One. 2016;11(10):e0165347.

    PubMed  PubMed Central  Google Scholar 

  28. Celik O, Hascalik S, Elter K, Tagluk ME, Gurates B, Aydin NE. Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways. Hum Reprod. 2008;23(11):2458–2465.

    CAS  PubMed  Google Scholar 

  29. Huang X, Chen L, Fu G, Xu H, Zhang X. Decreased expression of pigment epithelium-derived factor and increased microvascular density in ovarian endometriotic lesions in women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2012;165(1):104–109.

    CAS  PubMed  Google Scholar 

  30. Michiels C, Minet E, Mottet D, Raes M. Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes. Free Radic Biol Med. 2002;33(9):1231–1242.

    CAS  PubMed  Google Scholar 

  31. Defrere S, Gonzalez-Ramos R, Lousse JC, et al. Insights into iron and nuclear factor-kappa B (NF-kappaB) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol Histopathol. 2011;26(8):1083–1092.

    CAS  PubMed  Google Scholar 

  32. Wang F, He YL, Peng DX, Liu MB. Expressions of nuclear factor-kappaB and intercellular adhesion molecule-1 in endometriosis. Di Yi Jun Yi Da Xue Xue Bao. 2005;25(6):703–705.

    CAS  PubMed  Google Scholar 

  33. Donnez J, Nisolle M, Gillet N, Smets M, Bassil S, Casanas-Roux F. Large ovarian endometriomas. Hum Reprod. 1996;11(3):641–646.

    CAS  PubMed  Google Scholar 

  34. Muzii L, Bianchi A, Bellati F, et al. Histologic analysis of endometriomas: what the surgeon needs to know. Fertil Steril. 2007;87(2):362–366.

    PubMed  Google Scholar 

  35. Mirkin D, Murphy-Barron C, Iwasaki K. Actuarial analysis of private payer administrative claims data for women with endometriosis. J Manag Care Pharm. 2007;13(3):262–272.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akin Usta MD.

Additional information

Authors’ Note

A.U. contributed to data management and manuscript writing/editing. G.T. contributed to data collection and manuscript writing. C.B.B., E.A., and M.H. contributed to interpretation. E.A. contributed to protocol/project development, interpretation, management. All procedures performed were in accordance with the ethical standards of the institutional review board and with the Helsinki Declaration or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Usta, A., Turan, G., Altun, E. et al. The Usefulness of CD34, PCNA Immunoreactivity, and Histopathological Findings for Prediction of Pain Persistence After the Removal of Endometrioma. Reprod. Sci. 26, 269–277 (2019). https://doi.org/10.1177/1933719118768697

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719118768697

Keywords

Navigation